Program·Pitching sessions
Start-ups pitch to investors, and investors and pharma pitch back.
About the format
Pitching sessions put emerging companies in front of a jury of investors and industry experts. Reverse pitches turn the format around: venture investors and pharma explain what they are looking for.
Sessions are hosted by the Swiss Biotech Association, its chapters and partner organizations. In 2026, they included the Future Stars biotech pitch session, an AI-driven drug discovery session, an industrial biotechnology showcase, the SLAS start-up pitch showcase and Venturelab's Venture Leaders Biotech.
Reverse pitching sessions are among the best attended: top biotech VCs and corporate investors explain their investment thesis, what a fundable data package looks like and how to get a first meeting. The Global Innovation Showcase brings early-stage and late-stage start-ups from the Global Village delegations on stage.

Why take part
Investors and industry experts respond to every pitch in the room.
Investors and pharma share their investment thesis and strategic priorities with the founders they want to meet
Start-ups from the international delegations pitch to the Swiss ecosystem.
Last edition
Tuesday, 09:00
Reverse pitch: what top biotech VCs are looking for
Curie.Bio
Monday, 16:30
Future Stars: SBA biotech pitch session
Swiss Biotech Association
Monday, 14:30
AI-driven breakthroughs from target to therapy
Swiss Biotech Association
Monday, 17:45
Meet the Venture Leaders Biotech 2026
Venturelab
Tuesday, 12:15
The SLAS start-up pitch showcase
SLAS
Tuesday, 15:15
Reverse investor pitch
Swiss Biotech Association, YoungVC and Creadd Ventures
Pitching companies are selected by the session hosts. Register as a delegate and watch for calls for applications from the Swiss Biotech Association and its partners.
Program